Severe candidosis infections in neutropenic patient in onco-hematologic department;Infections candidosiques sévères chez le patient neutropénique en onco-hématologie pédiatrique

Archives de Pediatrie

Volumn 10, Issue SUPPL. 5, 2003, Pages

  Pellegrino, Béatrice ^a   Le Guyader, N ^a   Thien, Vu ^a   Fasola, S ^a   Auvrignon, A ^a   Leverger, G ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Antifungal agents; Candidiasis; Child; Hematologic diseases; Neutropenia; Oncology, medical

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; BLOOD CULTURE; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; CONFERENCE PAPER; DERMATOMYCOSIS; ENDOPHTHALMITIS; FEVER; HEPATOSPLENOMEGALY; HUMAN; INCIDENCE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPHYLAXIS; RISK FACTOR; SERODIAGNOSIS; TREATMENT PLANNING; BLOOD DISEASE; DECISION TREE; HOSPITALIZATION; REVIEW;

CANDIDIASIS; CHILD; DECISION TREES; HEMATOLOGIC NEOPLASMS; HUMANS; NEUTROPENIA; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0346217070     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (37)

1. Edwards JE, Jr, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, et al. International Conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997; 25: 43-59.
2. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. Gastroenterol 1967; 53: 845-55.
3. Odds FC. Candida infections: an overview. Crit Rev Microbiol 1987; 15: 1-5.
4. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733-8.
5. Van Belkum A, Melchers W, De Pauw BE, Scherer S, Quint W, Meis JF. Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients. J Infect Dis 1994; 169: 1062-70.
6. Seelig MS. The role of antibiotics in the pathogenesis of Candida infections. Am J Med 1966; 40: 887-917.
7. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994; 19: S8-13.
8. Sanchez V, Vazquez JA, Bath-Jones D, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993; 94: 577-82.
9. Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 1994; 32: 2299-300.
10. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case control study. J Clin Microbiol 1988; 26: 429-32.
11. Guiot HF, Fibbe WE, Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implication for empirical therapy and prophylaxis. Clin Infect Dis 1994; 18: 525-32.
12. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995; 21: 361-9.
13. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 5: 646-55.
14. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989; 87: 614-20.
15. Beck-Sagué CM, Jarvis WR, and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United-States, 1980-1990. J Infect Dis 1993; 167: 1247-51.
16. Grillot R and participants at the ECMM Candidemia Working Group. ECMM prospective epidemiological survey of candidemia in Europe: report from France (682 cases). Rev Iberoam Micol 2000; 17: S144.
17. Herbrecht R, Zamfir A, Letscher-Bru V. Candidoses viscérales. Rev Prat 2001; 51: 725-30.
18. Klein JJ, Watanakunakorn C. Hospital-acquired fungemia. Its natural course and clinical significance. Am J Med 1979; 67: 51-8.
19. Edwards JE, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophtalmitis. Medicine 1974; 53: 47-75.
20. Anttila VJ, Farkkila M, Jansson SE, Taavitsainen M, Kaukoranta-Tolvanen SS, Nordling S, et al. Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidasis. Eur J Clin Microbiol Infect Dis 1997; 16: 637-43.
21. Blade J, Lopez-Guillermo A, Rozman C, Granena A, Bruguera M, Bordas J, et al. Chronic systemic candidiasis in acute leukemia. Ann Hematol 1992; 64: 240-4.
22. Van Burik JH, Leisenring W, Myerson D, Hackman RC, Shulman HM, Sale GE, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine 1998; 77: 246-54.
23. Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. Am J Roentgenol 1997; 169: 1311-6.
24. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
25. th Annual ICAAC, San Francisco, 1999: 975.
26. Reisner BS, Woods GL. Times to detection of bacteria and yeasts in BACTEC 9240 blood culture bottles. J Clin Microbiol 1999; 37: 2024-6.
27. Sparrelid E, Hagglund H, Remberger M, Ringden O, Lonnqvist B, Ljungman P, et al. Bacteraemia during the aplastic phase after allogenic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795-800.
28. Fricker-Hidalgo H, Chazot F, Lebeau B, Pelloux H, Ambroise-Thomas P, Grillot R. Use of similated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur J Clin Microbiol Infect Dis 1998; 17: 113-6.
29. ECMM Working Group report. Survey of candidemia in Europe. ECMM 2000.
30. Anttila VJ, Ruutu P, Bondestam S, Jansson SE, Nordling S, Farkkila M, et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 1994; 18: 979-81.
31. Pagano L, Antinori A, Ammassari A, Mele L, Nosari A, Melillo L, et al. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol 1999; 63: 77-85.
32. Viscoli C, Girmenia C, Marinus A. Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organisation for Research and Treatment of Cancer. Clin Infect Dis 1999; 28: 1071-9.
33. Anaissie EJ, Rex JH, Uzun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104: 238-45.
34. Lortholary O, Dupont B. Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev 1997; 10: 477-504.
35. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000; 18: 3558-85.
36. Rex JH, Bennett JE, Sugar AM, Pappas PG, Serody J, Edwards JE, et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995; 21: 994-6.
37. Ladeb S, Herbrecht R, Escudier B, Dhedin N, Cordonnier C. Facteurs de croissance et infections. Med Mal Infect 1996; 12: 1129-39.